Drug Type AAV based gene therapy |
Synonyms rAAV Anc80 KCNQ4, rAAV Anc80KCNQ4 |
Target |
Mechanism Kv7.4 modulators(KCNQ voltage-gated potassium channel-4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hearing Loss | Discovery | US | 12 May 2021 |